Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global single use transfusion sets market was valued at USD 870 million in 2024 and is projected to reach USD 1.36 billion by 2031, exhibiting a CAGR of 6.7% during the forecast period. Single use transfusion sets are specialized medical devices designed for the administration of blood and blood products, manufactured from high-quality medical-grade materials to ensure patient safety and procedural efficiency.
This market growth is primarily driven by the increasing global demand for blood transfusions due to rising surgical procedures, trauma cases, and chronic conditions requiring blood products. The World Health Organization reports that approximately 118.5 million blood donations are collected globally each year, with 42% from high-income countries where transfusion infrastructure is most developed. The market expansion is further supported by advancements in healthcare infrastructure across emerging economies and increasing adoption of single-use devices to prevent hospital-acquired infections.
However, the market faces challenges from growing preference for alternative intravenous access methods and stringent regulatory requirements for medical device approval. The European Medical Device Regulation (MDR) 2017/745 and U.S. FDA's Quality System Regulation (QSR) require extensive clinical data and quality management systems, potentially delaying market entry for new entrants.
Regionally, North America dominated the market with 38.2% share in 2023 due to well-established healthcare infrastructure and high healthcare expenditure. The Asia-Pacific region is expected to show the highest growth rate at 8.2% CAGR, driven by increasing healthcare investments and rising surgical procedures in countries like India and China.
The market is moderately consolidated with key players including Becton Dickinson, Fresenius Kabi, Smiths Medical, and B.Braun holding significant market share. These companies are focusing on product innovation and strategic partnerships to expand their market presence, with recent developments including the introduction of safety-engineered transfusion sets to reduce needlestick injuries.
Rising Surgical Procedures and Blood Transfusions
The global increase in surgical procedures, particularly elective surgeries postponed during the pandemic, has significantly driven demand for single-use transfusion sets. Hospitals and surgical centers are performing more procedures requiring blood transfusions, with total procedures increasing by 18% in 2023 compared to pre-pandemic levels.
Growing Emphasis on Infection Control
Healthcare facilities globally are adopting stricter infection control protocols, making single-use medical devices the standard. This shift has driven 32% growth in single-use transfusion set adoption in developed markets, reducing cross-contamination risks significantly compared to reusable alternatives.
➤ Hospitals report 67% reduction in transfusion-related complications when using single-use systems with integrated safety features
Regulatory bodies are increasingly mandating single-use devices for procedures with high contamination risk, contributing to market expansion even in price-sensitive markets.
MARKET CHALLENGES
High Initial Investment Requirements
The transition to single-use transfusion systems requires significant capital investment in both manufacturing and healthcare facility settings. Manufacturers face R&D costs averaging $2.5M per product line, while hospitals must invest in training and storage infrastructure. This creates barrier to entry especially in emerging markets where healthcare budgets are constrained.
Other Challenges
Supply Chain Complexities
The global supply chain for medical grade plastics and specialty materials faces periodic disruptions, with lead times increasing by 40% in 2023. Price volatility in raw materials, particularly medical-grade polymers, adds unpredictability to manufacturing costs and final product pricing.
Price Sensitivity in Emerging Markets
In developing economies, healthcare budgets remain constrained, with 68% of hospitals in these regions reporting cost as the primary factor in device selection. Single-use transfusion sets typically cost 3-5x more per procedure than reusable alternatives, creating adoption barriers despite superior safety profiles.
Integration with Automated Systems
The integration of single-use transfusion sets with automated medication dispensing systems and electronic health records creates opportunities for efficiency improvements. Hospitals implementing integrated systems report 45% reduction in medication errors and 31% faster transfusion processes. This creates cross-selling opportunities for manufacturers offering comprehensive solutions.
Expansion in Home Healthcare
Post-pandemic healthcare delivery continues shifting toward home-based care, with 42% growth in home transfusion services in developed markets. This creates demand for compact, user-friendly single-use transfusion sets designed for non-clinical environments, opening new market segments beyond traditional hospital settings.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Standard Transfusion Sets dominate hospital procurement due to their versatility and cost-effectiveness across various transfusion scenarios, while specialized sets gain traction in niche surgical applications requiring specific configurations. |
| By Application |
|
Blood Transfusion Procedures maintain the largest market share as they represent the primary use case in hospital settings, with increasing demand for plasma exchange systems driven by growing autoimmune disease prevalence and specialized treatment protocols. |
| By End User |
|
Hospitals & Transfusion Centers constitute the dominant segment due to their central role in transfusion medicine, with ambulatory centers showing the fastest growth as outpatient procedures expand and specialty clinics develop specialized transfusion services for specific patient populations. |
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
Baxter International Inc. (USA) dominates the market with its comprehensive portfolio of single-use transfusion sets, holding approximately 25% market share through extensive distribution network and strong R&D capabilities in blood management solutions.
Fresenius SE & Co. KGaA (Germany) follows as the second largest player, focusing on integrated blood management solutions and cost-effective manufacturing of high-quality transfusion sets for global markets.
B. Braun Melsungen AG (Germany) and Terumo Corporation (Japan) continue to expand through strategic acquisitions and partnerships, enhancing their geographical presence in Asia-Pacific and European markets.
Medtronic Plc (Ireland) and Haemonetics Corporation (USA) focus on technological innovations, developing advanced filtration systems and safety features to differentiate their offerings in competitive tenders.
List of Key Single Use Transfusion Sets Companies ProfiledBaxter International Inc. (USA)
Fresenius SE & Co. KGaA (Germany)
B. Braun Melsungen AG (Germany)
Terumo Corporation (Japan)
Medtronic Plc (Ireland)
Haemonetics Corporation (USA)
The global market for single use transfusion sets is experiencing significant growth due to increasing surgical procedures and emphasis on infection control. Hospitals and clinics are rapidly adopting disposable sets to eliminate cross-contamination risks, with market analysts projecting 7.2% annual growth through 2026. This trend is particularly strong in emerging markets where healthcare infrastructure expansion is driving demand.
Other TrendsRegulatory Compliance Driving Standardization
Stringent FDA and EU regulations regarding medical device safety are pushing manufacturers toward standardized, pre-sterilized single use transfusion sets. This has accelerated adoption in North American and European markets where compliance requirements are most stringent. Manufacturers are responding with enhanced quality control processes and material innovation.
Recent advancements in polymer technology have enabled thinner, more flexible tubing without compromising safety. This has reduced material costs by approximately 18% while maintaining compliance with international standards. The shift toward cost-effective manufacturing is particularly evident in Asian markets where production scales have increased dramatically.
Sustainability Concerns and Biodegradable Alternatives
Environmental concerns are driving research into biodegradable single use transfusion sets. While still representing a small segment, biodegradable options are gaining traction in environmentally conscious markets. Current development focuses on maintaining material integrity during shelf life while ensuring proper degradation post-use.
The integration of RFID and barcode technologies into single use transfusion sets is becoming standard in developed markets. This supports inventory management, reduces human error, and provides valuable usage data for healthcare providers. The technology adoption rate has increased by 45% over the past two years in North American hospitals.
Regional Analysis: Single Use Transfusion Sets MarketEurope
Europe maintains strong position with sophisticated healthcare systems and high regulatory standards. The market benefits from well-established distribution networks and trained medical professionals. EU directives on medical devices ensure product quality and safety. Northern European countries show particularly high adoption rates while Southern Europe shows growth potential. Cross-border healthcare collaborations and standardized practices support market stability. The region shows resilience against economic fluctuations through sustained healthcare investments.
Asia-Pacific
Asia-Pacific demonstrates exceptional growth potential with rapidly developing healthcare infrastructure. Countries like China and India represent massive patient populations driving demand. Increasing healthcare expenditure and medical tourism contribute to market expansion. Government initiatives to improve healthcare access in rural areas create new opportunities. The region benefits from cost-effective manufacturing and export capabilities while maintaining quality standards. Regional cooperation and knowledge sharing accelerate adoption of advanced medical technologies.
Latin America
Latin America shows consistent growth with improving economic conditions and healthcare reforms. Countries like Brazil and Argentina show strong public healthcare systems while private sector growth continues. Regional economic blocs facilitate trade and standardization of medical devices. Increasing healthcare coverage and access to surgical procedures drive demand. The region shows potential for increased market penetration as economic conditions improve and healthcare becomes priority.
Middle East & Africa
Middle East & Africa show developing market characteristics with significant growth potential. Gulf countries show rapid development with world-class healthcare infrastructure while African nations show gradual improvement. International collaborations and investments bring advanced medical technologies to the region. Economic diversification in Gulf states includes healthcare development as priority. African nations show increasing awareness and gradual adoption of single-use medical devices. The region represents future growth opportunities as healthcare systems develop.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2031. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global single use transfusion sets market was valued at USD 870 million in 2024 and is projected to reach USD 1.36 billion by 2031.
-> The market is expected to grow at a CAGR of 6.7% during 2024-2031.
-> Major companies include Fresenius Kabi, BD, B.Braun, Smiths Medical, and Helm Medical.
-> Market segments by type include A1 (With Injection), A2 (Without Injection), B1 (With Injection Piece), and B2 (Without Injection Parts).
-> North America held 38.2% market share in 2023, while Asia-Pacific is expected to grow at 8.2% CAGR.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates